about
Steroidogenesis in the skin: implications for local immune functionsThe antimicrobial protein REG3A regulates keratinocyte proliferation and differentiation after skin injuryKey role of CRF in the skin stress response system.Dicer in immune cell development and function.Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway.cAMP-responsive element modulator α (CREMα) suppresses IL-17F protein expression in T lymphocytes from patients with systemic lupus erythematosus (SLE).IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonistTetraspanin CD151 plays a key role in skin squamous cell carcinoma.Effects of Human Mesenchymal Stem Cells Transduced with Superoxide Dismutase on Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice.Signaling via the IL-20 receptor inhibits cutaneous production of IL-1β and IL-17A to promote infection with methicillin-resistant Staphylococcus aureus.Serum levels of selected Th17 and Th22 cytokines in psoriatic patients.The emerging role of circulating microRNAs as biomarkers in autoimmune diseases.Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus.Propionibacterium acnes Induces an IL-17 Response in Acne Vulgaris that Is Regulated by Vitamin A and Vitamin D.Chronic exposure to stress predisposes to higher autoimmune susceptibility in C57BL/6 mice: glucocorticoids as a double-edged sword.Withasteroid B from D. metel L. regulates immune responses by modulating the JAK/STAT pathway and the IL-17+ RORγt+ /IL-10+ FoxP3+ ratio.Synthesis and activity of the salicylic acid ester of bakuchiol in psoriasis-surrogate keratinocytes and skin substitutes.
P2860
Q26830355-598B8B2D-4E1C-4F3F-886C-EE29CB4519E7Q28507522-5B1B150F-3DC0-4F84-B5C7-D3D0E9459A4DQ34363640-9F4CE8B7-4F88-4967-A377-77913008988BQ34389645-65DD2F02-2CFE-41ED-8FA5-AE1EE1467986Q35047990-0877E510-C991-4415-ADF7-FFC8F0E71F5EQ35763036-50043E4B-44E6-45A9-ABBB-02B42BB886CCQ35779110-6DC74B8B-341F-4C5A-8310-0D8500B3C263Q36350751-369AF249-2EB6-4EBB-884E-1FED19086FFBQ36580091-242CA556-128C-4FF4-8474-85FC95BAEC5EQ37040753-F13511AE-38C7-44AE-82CA-ABE5D1988CFDQ37322356-BAC3AF28-5258-43D0-ABC0-54B944CEB76BQ38222306-4490E566-2D48-4C61-9C58-60F1C5DC60EBQ38975627-DA9D43DC-5395-4EB7-A172-C799296CDCE7Q42205561-F056E471-8D74-4674-A668-092C3AD14AF9Q45969202-F36A45CD-13CC-469F-8463-E2D9DB33EA48Q48272707-364EEC95-7CA0-4713-82BA-6B1B87CE660DQ51061259-2DB4CAFC-42F8-401C-9543-5859CE0AD656
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Psoriasis and other Th17-mediated skin diseases.
@en
Psoriasis and other Th17-mediated skin diseases.
@nl
type
label
Psoriasis and other Th17-mediated skin diseases.
@en
Psoriasis and other Th17-mediated skin diseases.
@nl
prefLabel
Psoriasis and other Th17-mediated skin diseases.
@en
Psoriasis and other Th17-mediated skin diseases.
@nl
P356
P1433
P1476
Psoriasis and other Th17-mediated skin diseases.
@en
P2093
Ryosuke Hino
Tomoko Mori
P304
P356
10.7888/JUOEH.32.317
P577
2010-12-01T00:00:00Z